Background {#s1}
==========

Breast cancer is an issue of medical importance worldwide \[[@R01]-[@R03]\]. Treatments such as radiation therapy, chemotherapy, surgery, immunotherapy, and hormone therapy are available with debatable efficiency. Known drugs in this context is under constant debate for efficiency and drug resistance \[[@R04],[@R05]\]. The use of an FDA approved drug docetaxel as a therapeutic agent in cancer patients are known \[[@R06]-[@R10]\]. Lipocalin 2 (Lcn2, neutrophil gelatinase-associated lipocalin ([Figure 1](#F1){ref-type="fig"}) is a member of the lipocalin family and a known target for breast cancer \[[@R11]-[@R18]\]. Therefore, it is of interest to use Docetaxel as a scaffold to design molecules with improved efficiency from naturally derived phytochemicals.

Methods: {#s2}
========

Protein preparation: {#s2a}
--------------------

The X-ray crystallographic structure of the lipocalin 2 with 2.6Å resolution was retrieved from Protein Data Bank (PDB) with PDB ID: 1DFV was used in this study using standard procedure \[[@R19]\].

Ligand preparation: {#s2b}
-------------------

Structure of Docetaxel and its 10 analogues were downloaded from the PUBCHEM database in SDF format and converted to PDF file format with the help of the Online Smile Translator.

Molecular docking analysis: {#s2c}
---------------------------

Molecular docking analysis was completed using PATCHDOCK following standard protocols \[[@R20],[@R21]\]. The docked structure was examined using Ligplot \[[@R22]\].

Results and discussion: {#s3}
=======================

[Table 1](#T1){ref-type="table"} shows the Molecular docking analysis of Docetaxel analogues as duel Lipocalin 2 inhibitors. We document 10 analogues (4Deacetyltaxol, 7Acetyltaxol, Cabazitaxel, Cephalomannine, Docetaxal, Deacetyltaxol, Docetaxeltrihydrate, Ortataxel, Paclitaxel, Taxoline) with desirable binding with the Lipocalin 2 in comparison with Docetaxel ([Table 1](#T1){ref-type="table"}). Results of the analogue deacetyltaxol have the good binding energy (-132-89 kcal/mol). [Figure 2](#F2){ref-type="fig"} shows ligand-protein interaction drawn using LigPlot. The interacting residues with optimal hydrogen bonding patterns are shown. An increased amount of hydrophobic atoms in the active center of drug--target boundary enlarged the biological action of the lead \[[@R23]\].

Conclusions: {#s4}
============

We document 10 analogues (4-deacetyltaxol, 7-acetyltaxol, cabazitaxel, cephalomannine, docetaxal, deacetyltaxol, docetaxeltrihydrate, ortataxel, paclitaxel and taxoline) with desirable binding features with the Lipocalin 2 in comparison with Docetaxel for further in vivo and in vitro validation.
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###### Molecular docking analysis of docetaxel analogues as duel lipocalin 2 inhibitors

  S. No   Compound name         Score   ACE        Atomic interaction   Ligand atom   Distance   No of non bonded interaction
  ------- --------------------- ------- ---------- -------------------- ------------- ---------- ------------------------------
  1       Docetaxel             5804    -54.82     LYS 125              NZ-O          1.53       57
                                                   LYS 134                            3.02       
  1       4Deacetyltaxol        6474    -147.98    TYR 52               OH-O          2.87       117
                                                   ARG 81               NH-0          1.49       
                                                   LYS 134              NZ-O          3.32       
  2       7Acetyltaxol          6252    -103.92    TRP 79               NE-O          2.3        114
                                                   ARG 81               NH2-O         3.29       
                                                   LYS 125              NZ-O          2.83       
                                                   SER 127              OG-O          1.39       
                                                   LYS 134              NZ-O          3.14       
  3       Cabazitaxel           5952    -50.11     LYS 125              NZ-O          2.24       69
                                                   SER 127              OG-O          2.44       
                                                   LYS 134              NZ-O          3.29       
                                                   LYS 34               NZ-O          3.03       
  4       Cephalomannine        6794    -113.10    TYR 52               OH-O          2.62       110
                                                   ARG 81               NH1-O         1.43       
                                                   ARG 81               NH2-O         2.17       
                                                   LYS 134              NZ-O          1.84       
  5       Docetaxal             6404    -111.73    TYR 52               OH-O          3          108
                                                   TYR 52               OH-O          2.81       
                                                   LYS 125              NZ-O          3.28       
                                                   LYS 134              NZ-O          2.63       
  6       Deacetyltaxol         5694    -132.89    LYS 125              NZ-O          3.04       87
                                                   SER 127              OG-O          2.68       
                                                   LYS 134              NZ-O          2.05       
  7       Docetaxeltrihydrate   6022    -63.23     ARG 81               NH1-O         2.39       84
                                                   ARG 81               NH2-O         1.34       
  8       Ortataxel             6204    -55.51     LYS 125              NZ-O          2.26       74
                                                   LYS 134              NZ-O          3.05       
  9       Paclitaxel            6438    -121.39    TYR 52               OH-O          2.4        148
                                                   LYS 134              NZ-O          2.43       
  10      Taxoline              6824    -74.36     TYR 52               OH-O          2.37       83
                                                   ARG 81               NH1-O         2.78       
                                                   ARG 81               NH2-O         2.94       
                                                   LYS 125              NZ-O          2.87       
                                                   LYS 134              NZ-O          2.65       

![Structure of lipocalin 2](97320630016438F1){#F1}

![Ligplot analysis of docked complex showing interaction of lipocalin 2 with (a) 4Deacetyltaxol; (b) 7Acetyltaxol; (c) cabazitaxel; (d) Cephalomannine; (e) Docetaxal; (f) Deacetyltaxol; (g) Docetaxeltrihydrate; (h) ortataxel; (i) paclitaxel; (j) taxoline](97320630016438F2){#F2}
